Literature DB >> 11172626

Cytochrome P450 enzymes in the bioactivation of vitamin D to its hormonal form (review).

K Wikvall1.   

Abstract

The formation of 1alpha,25-dihydroxyvitamin D3 requires a 25-hydroxylation followed by a 1alpha-hydroxylation catalyzed by cytochrome P450 (CYP) enzymes in liver and kidney. The aim of this review is to give a brief summary of our research on the cytochrome P450 enzymes catalyzing the 25-hydroxylation and 1alpha-hydroxylation and to discuss the results in relation to other published literature on these enzymes. Two hepatic P450 enzymes catalyzing 25-hydroxylation of vitamin D3 exist in mammalian liver - one mitochondrial and one microsomal. The mitochondrial vitamin D3 25-hydroxylase is apparently identical with CYP27A, an obligatory enzyme in bile acid biosynthesis in liver. The microsomal 25-hydroxylase has been purified to apparent homogeneity from pig liver. The enzyme catalyzed 25-hydroxylation of vitamin D3, 1alpha-hydroxyvitamin D3, vitamin D2 and 1alpha-hydroxyvitamin D2. A cDNA encoding pig liver microsomal vitamin D3 25-hydroxylase has been isolated in this laboratory. The primary structure of vitamin D3 25-hydroxylase shows 70-80% identity with members of the CYP2D subfamily and has been designated CYP2D25. Three different 1alpha-hydroxylating cytochromes P450 in kidney, i.e. CYP27A, CYP27B and a microsomal 1alpha-hydroxylase, have been described. Mitochondrial cytochrome P450, catalyzing 1alpha-hydroxylation and 27-hydroxylation but not 24-hydroxylation of 25-hydroxyvitamin D3, was partially purified from pig kidney. Purification and inhibition experiments as well as experiments with a monoclonal antibody against CYP27A indicated that one single enzyme catalyzes both 1alpha- and 27-hydroxylation. Treatment of rats with a single i.v. dose of 1alpha,25-dihydroxyvitamin D3 resulted in a marked suppression of CYP27A mRNA levels in kidney. The results suggest a role for CYP27A as a renal mitochondrial 1alpha-hydroxylase. Subsequently, several research groups reported the isolation of cDNA encoding mouse, rat and human kidney 25-hydroxyvitamin D3 1alpha-hydroxylase. The amino acid sequences deduced from these cDNA clones were similar but differed from that of CYP27A. This 1alpha-hydroxylase constitutes a new CYP27 subfamily, CYP27B. The expression of CYP27B was found to be influenced by vitamin D status and parathyroid hormone. Mutations in the CYP27B gene have been identified in patients with pseudovitamin D-deficiency rickets. A microsomal P450 catalyzing 1alpha-hydroxylation of 25-hydroxyvitamin D3 has been purified to apparent homogeneity from pig kidney. This finding demonstrate the presence of a microsomal 1alpha-hydroxylase in addition to the mitochondrial 1alpha-hydroxylases in kidney. The relative importance and regulation of the different renal 1alpha-hydroxylases in the bioactivation of vitamin D3 under normal and pathological conditions will be subject for future studies.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11172626     DOI: 10.3892/ijmm.7.2.201

Source DB:  PubMed          Journal:  Int J Mol Med        ISSN: 1107-3756            Impact factor:   4.101


  13 in total

1.  Chemoprevention of prostate cancer by cholecalciferol (vitamin D3): 25-hydroxylase (CYP27A1) in human prostate epithelial cells.

Authors:  Erik J Tokar; Mukta M Webber
Journal:  Clin Exp Metastasis       Date:  2005       Impact factor: 5.150

2.  Bone disorders in experimentally induced liver disease in growing rats.

Authors:  Viktória Ferencz; Csaba Horváth; Béla Kári; János Gaál; Szilvia Mészáros; Zsuzsanna Wolf; Dalma Hegedus; Andrea Horváth; Anikó Folhoffer; Ferenc Szalay
Journal:  World J Gastroenterol       Date:  2005-12-07       Impact factor: 5.742

3.  In the search for reliable biomarkers for the early diagnosis of autism spectrum disorder: the role of vitamin D.

Authors:  Afaf El-Ansary; John J Cannell; Geir Bjørklund; Ramesa Shafi Bhat; Abeer M Al Dbass; Hanan A Alfawaz; Salvatore Chirumbolo; Laila Al-Ayadhi
Journal:  Metab Brain Dis       Date:  2018-03-01       Impact factor: 3.584

4.  Possible involvement of pregnane X receptor-enhanced CYP24 expression in drug-induced osteomalacia.

Authors:  Jean Marc Pascussi; Agnes Robert; Minh Nguyen; Odile Walrant-Debray; Michèle Garabedian; Pascal Martin; Thierry Pineau; Jean Saric; Fréderic Navarro; Patrick Maurel; Marie Josè Vilarem
Journal:  J Clin Invest       Date:  2005-01       Impact factor: 14.808

5.  Functional Characterization of Three Specific Acyl-Coenzyme A Synthetases Involved in Anaerobic Cholesterol Degradation in Sterolibacterium denitrificans Chol1S.

Authors:  Markus Warnke; Tobias Jung; Christian Jacoby; Michael Agne; Franziska Maria Feller; Bodo Philipp; Wolfgang Seiche; Bernhard Breit; Matthias Boll
Journal:  Appl Environ Microbiol       Date:  2018-03-19       Impact factor: 4.792

6.  Expression of transcripts related to intestinal ion and nutrient absorption in pregnant and lactating rats as determined by custom-designed cDNA microarray.

Authors:  Jarinthorn Teerapornpuntakit; Amornpan Klanchui; Nitsara Karoonuthaisiri; Kannikar Wongdee; Narattaphol Charoenphandhu
Journal:  Mol Cell Biochem       Date:  2014-02-12       Impact factor: 3.396

7.  Steroid biotransformations in biphasic systems with Yarrowia lipolytica expressing human liver cytochrome P450 genes.

Authors:  Andreas Braun; Martina Geier; Bruno Bühler; Andreas Schmid; Stephan Mauersberger; Anton Glieder
Journal:  Microb Cell Fact       Date:  2012-08-09       Impact factor: 5.328

Review 8.  Glyphosate, pathways to modern diseases II: Celiac sprue and gluten intolerance.

Authors:  Anthony Samsel; Stephanie Seneff
Journal:  Interdiscip Toxicol       Date:  2013-12

Review 9.  The pleiomorphic actions of vitamin D and its importance for children.

Authors:  Se Young Kim
Journal:  Ann Pediatr Endocrinol Metab       Date:  2013-06-30

10.  Elevated serum 1,25(OH)2-vitamin D3 level attenuates renal tubulointerstitial fibrosis induced by unilateral ureteral obstruction in kl/kl mice.

Authors:  Yujing Sun; Gengyin Zhou; Ting Gui; Aiko Shimokado; Masako Nakanishi; Kosuke Oikawa; Fuyuki Sato; Yasuteru Muragaki
Journal:  Sci Rep       Date:  2014-10-09       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.